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A BST R AC T   
 
Aim: To measure serum leptin, homocysteine concentrations and insulin resistance in active and 
remission stages of children with nephrotic syndrome (NS) and to investigate their role in NS 
pathogenesis. 
Methods: A total of 70 children were included in the study, 40 patients who had been diagnosed with 
NS and 30 healthy patients were control. Changes in plasma concentration of the serum 
homocysteine, leptin, and insulin were measured and compared with the other parameters in the 
groups. 
Results: Serum leptin concentrations in active phase were lower than the remission phase (1.48 ± 
0.09 ng/dl, 1.84 ± 1.64 ng/ml, p<0.05). Also, serum homocysteine concentrations in NS group during 
the active phase were lower than the remission phase and the control group (6.45±2.54 ng/dl, 
9.35±2.99 ng/ml, 7.76± 1.97 ng/ml, p<0.05). The serum fasting insulin concentrations and 
homeostatic model assessment for insulin resistance (HOMA-IR) values of remission phase were 
significantly higher than those of active phase (p<0.05). A positive relationship was found between 
the homocysteine concentrations and the body mass index of the patient; whereas, a negative 
relationship was detected between erythrocyte sedimentation rate (ESR), and the LDL-cholesterol 
concentrations (p<0.05). ESR was found as the only factor associated with lower concentrations of 
homocysteine during the active phase (r:-0.592, p<0.05).   
Conclusion: In this study, we demonstrated that serum leptin and homocysteine concentrations 
decreased in active phase and increased in remission phase in children with NS.  Insulin resistance 
could also develop as a result of steroid use in a short period of time in these patients. 
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Introduction 
Nephrotic syndrome (NS) is a clinical condition 
characterized by heavy proteinuria, 
hypoalbuminemia, edema and hyperlipidemia. 
Approximately 80% of the nephrotic 
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syndromes seen in children present as minimal 
lesions that respond to steroid treatment [1]. 
Though NS is frequently encountered, its 
etiopathogenesis is not precisely clarified; 
however, genetic factors and immunology are 
suspected [2]. Today, genetic and metabolic 
studies aimed at explaining the development of 
the disease have been vigorously undertaken. It 
is known that patients given steroid treatment 
have a tendency of insulin resistance, obesity 
and endothelial dysfunction particularly in 
children [3]. 
Leptin, which is a 167-amino acid polypeptide, 
is synthesized in tissues like the adipose tissue, 
the placenta, the gastrointestinal tract and 
neuronal tissues, but the activity mainly occurs 
in the adipose tissue [4,5]. Body fat and serum 
leptin concentrations are directly proportional 
therefore, leptin concentrations are increased 
for obese person. Insulin resistant is determined 
in rodents which has leptin resistance and 
deficiency [6]. Leptin effects the 24-hour 
urinary protein amounts in children and is 
associated with the child’s body weight and the 
severity of the disease [7]. 
Homocysteine, a thiol-containing amino acid, is 
generated by intracellular demethylation of 
dietary methionine, which is catabolized to 
form either cystathionine or cysteine [8]. 
Hyperhomocysteinemia is an independent risk 
factor for coronary heart disease, and display 
endothelial dysfunction. [9].  Renal function 
influences plasma homocysteine 
concentrations, and various reports have shown 
that plasma homocysteine concentrations may 
be lowered or elevated in children with NS 
compared to healthy controls [10].  
We hypothesized that leptin and homocysteine 
metabolism is impaired in children with 
idiopathic nephrotic syndrome and during 
steroid treatment. The present study was 
designed to assess the changes in plasma 
concentration of serum homocysteine, leptin 
and insulin in patients with nephrotic syndrome 
in active and remission phase after steroid 
treatment.  
 
Materials and Methods 
This study was conducted in children for the 
first time diagnosed with NS at our Pediatric 
Nephrology. This study was approved by the 
Medical Ethics Committee of University of 
Health Sciences, Istanbul Haseki Teaching 
Hospital (Approval date and number: 
29.05.09/43). Furthermore, study was 
conducted in accordance with the revised 
Helsinki Declaration. The parents of the 
children in the patient and the control groups, 
as well as all children over 12 years of age, were 
informed in detail about the study, and 
informed consent with signature was received. 
The power calculation for the present study 
based on an effect size of 0.5 for leptin (ng/ml), 
a standard deviation of 2 (ng/ml) and an alpha 
level set at 0.05. Required sample size to get a 
power of 0.8 according to these assumptions 
was 30 patients for each group. Number of 10 
patients were added as extra cases in case of 
withdrawal or drop out possibility. Therefore, 
at the end of study number of patients were 40 
while control were 30.   
The inclusion criteria to for the study were as 
follows: patients who were first diagnosed with 
NS between the ages of two and sixteen, 
responded to steroid treatment, did not have an 
additional disease. Blood samples were 
obtained first on admission as active phase 
(proteinuria), second at the end of treatment as 
remission phase (non-proteinuria). In the first 
step of the study, patients who had proteinuria 
above 40 mg/m2/hour, serum albumin 
concentrations below 2.5 gr/dl and 
hyperlipidemia were primarily evaluated 
during the active phase, or proteinuria phase, 
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prior to the start of steroid treatment. Then, 
these patients were given 2 mg/kg/day 
prednisolone as stated in the steroid treatment 
protocol. To assess the responsiveness to the 
steroid treatment, it was accepted that 
proteinuria in urine measured with a dipstick 
should be found in trace amounts, negative or 
under 4 mg/m2/hour, and that serum albumin 
concentrations should be over 3.5 g/l for three 
consecutive days for four weeks. Afterward, the 
same dosage of steroids was kept on every other 
day for the following four weeks. The steroid 
treatment was then gradually decreased and 
carried on fulfilling five months. Remission 
phase blood samples were obtained at the end 
of treatment. The systemic examinations of 
patients were carried out after their detailed 
anamneses and medical histories were obtained 
in both phases. As control group, age-sex 
matched thirty healthy children were chosen to 
determine normal leptin and homocysteine 
concentrations.  
Blood samples were obtained after 12 hours 
fasting from patients who were included in the 
study and centrifuged at 1300 rpm for half an 
hour. Serum samples were taken into fine tubes 
and stored at -20°C. Routine biochemical 
examinations were practiced by Abbott C-
16000 chemistry analyzer, and standard 
conventional methods were performed. Leptin 
concentrations were determined by enzyme-
linked quantitative immunological 
measurement technique, using a Leptin ELISA 
kit (BioSource LEPTİN EASIA®, Nivelles 
Belgium). Homocysteine concentrations, 
however, were determined by use of an 
IMMULITE 2000® homocysteine kit and a 
competitive immunity measurement method. 
Insulin concentrations was measured by a 
chemiluminescent immunoassay method 
(ADVIA Centaur analyzer; Bayer Diagnostics) 
on fasting blood samples. HOMA-IR was 
calculated as [fasting glucose (mg/dl) x fasting 
insulin (lU/ml)/405] [11].  Intra assay and inter-
assay variations for the concentrations of leptin, 
homocysteine and insulin variables were 
calculated with the formula (CV: Standard 
Deviation/Mean).   
 
Statistical analysis 
Statistical analyses of the data were performed 
using the Statistical Package for the Social 
Sciences (SPSS), version 19, program (SPSS 
Inc., Chicago, IL, USA). All continuous values 
were presented as mean ± standard deviation, 
where suitable. The categorical values were 
presented as the frequency and percentage. 
Categorical variables were compared using 
Pearson’s chi-squared test. Independent 
samples t-test was used for comparing two 
groups. Paired data were analyzed using paired 
samples t-test when data were normally 
distributed. General linear model was used for 
adjusting the effect of BMI confounder.  The 
Spearman correlation coefficient was 
calculated to evaluate the correlation between 
the continuous variables. The values 




Demographics, anthropometric variables and 
arterial blood pressures of the study groups are 
reported in Table 1. When the biochemical 
parameters of the patients with nephrotic 
syndromes in their active (proteinuria) phases 
and remission phases (non-proteinuria) were 
compared, as expected, total protein, albumin, 
cholesterol, LDL-cholesterol, triglyceride and 
IgM concentrations of patients in their active 
phases were found to be significantly different 
than those concentrations found during their in 
remission phases (Table 2). The serum fasting 
insulin concentrations and HOMA-IR values of  
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remission phase were significantly higher than 
those of active phase (p<0.05).  
The active and remission phases of the patients 
and the leptin and homocysteine values of the 
control group are shown in Table 3. When we 
analysed leptin and homocysteine 
concentrations, we considered BMI as a 
confounder which was a significant different 
between the study and the control group. The 
serum leptin concentrations in active phase 
were lower than the remission phase (1.48 ± 
0.09 ng/dl, 1.84 ± 1.64 ng/ml, p<0.05). Also, 























group during the active phase were lower than 
the remission phase and the control group 
(6.45±2.54 ng/dl, 9.35±2.99 ng/ml, 7.76± 1.97 
ng/ml, p<0.05). In brief, the average 
homocysteine concentrations of the study 
groups can be formulated in ascending order as 
“active phase < control group < remission 
phase” (Table 3). Effective demographical, 
clinical and laboratory values on the reduction 
of serum homocysteine concentrations during 
the active phases of patients with NS were 
assessed.  
A positive relationship was determined 
between homocysteine concentrations, the 
body mass index (BMI) of patients and their 
serum IgG concentrations; whereas, a negative 
relationship was detected between the 
erythrocyte sedimentation rate, and the total 
cholesterol and LDL-cholesterol concentrations 























The factors causing low concentrations of 
homocysteine that were revealed via the 
Spearman correlation analysis were then tested 
to determine the independent predictor by 
implementing a Stepwise Linear Logistic 
Regression analysis. BMI, serum IgG 
concentrations, ESR, cholesterol, LDL-
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cholesterol concentrations, which are some 
factors that may affect homocysteine 
concentrations, were included in the model. As 
a result of the administration of this model, an 
increase in sedimentation rate was found as the 
only factor associated with lower 
concentrations of homocysteine during the 
active phase of patients with NS. 
 
Discussion 
The etiopathogenesis of steroid-sensitive NS 
has not been clearly identified. In the literature, 
it has been revealed that there are many factors 
stimulating the disease, and as a consequence of 
these factors, the illness commences after a 
series of immunological events [2,3,10]. Today, 
there are studies proceeding that will be able to 
shed light on NS’s etiopathogenesis. It is not yet 
clearly known whether the changes in leptin 
and homocysteine concentrations occur as a 
result of protein loss due via urine, the main 
cause of the illness, or whether there are other 
factors that contribute to the formation of NS 
[12-16]. We targeted to determine the leptin and 
serum homocysteine concentrations and the 
related factors in our patient group. In addition, 
we aimed to observe the effect of steroids on the 
insulin metabolism in the treatment of NS.  
Glomerular dysfunction develops in NS, and 
heavy proteinuria is thus observed. Some 
studies have shown that leptin excretion 
through urine increases in children with NS 
during the proteinuria phase. Parallel to this, the 
serum leptin concentrations of these children 
were reduced and both urine and serum leptin 
concentrations returned to normal during the 
remission phase of the disease [12,13]. In other 
studies, however, it has been noted that though 
patients’ leptin excretion increased during the 
proteinuria phase, there was no alteration in 
their serum leptin concentrations [12-14]. 
Therefore, the condition of the serum leptin 
concentrations in children with NS and the 
relationship between these concentrations and 
the disease’s pathogenesis remain unclear and 
controversial. Although the serum leptin 
concentrations of our patients during the 
proteinuria phase were determined to be lower 
than during the non-proteinuria phase and 
lower than the concentrations in the healthy 
children of the control group. The systemic 
elimination of leptin that is circulating in the 
blood happens through the kidneys. Leptin is 
not metabolized by the kidneys and is thus 
excreted as unimpaired proteins [17]. 
Therefore, in parallel with the daily urine 
decrease in children with chronic renal failure, 
the amount of leptin excreted via urine also 
diminishes and the serum leptin concentrations 
increase [3,15,16]. In NS, however, increased 
protein filtration causes leptin excretion via 
urine to increase. Though urinary leptin 
concentrations were not studied in our study, it 
was determined that leptin excretion with urine 
increased and the serum leptin concentrations 
decrease significantly. In a similar study, 
urinary leptin excretion is found as increased 
while serum leptin concentration is decreased. 
Serum leptin concentration plays an important 
role in the pathophysiology of NS (18) 
Homocysteine, not involved in the 20 amino 
acids among the structural elements of proteins, 
is an amino acid involving thiol. Homocysteine, 
synthesized in the liver, muscle and other 
tissues, is excreted via urine from the kidneys 
after being metabolized with remethylation and 
transsulphuration reactions [19]. It has been 
shown that plasma homocysteine 
concentrations are inversely correlated with 
creatinine clearance, and 
hyperhomocysteinemia is often seen in patients 
with renal failure [20]. Moreover, 
homocysteine plays a significant role in 
endothelial damage and in the formation of 
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atherosclerosis developed as a consequence of 
this damage. It has been reported that 
homocysteine prominently increases in patients 
with chronic renal failure, diabetes, obesity, 
hypertension and metabolic syndrome 
prominently and leads to endothelial 
dysfunction [21,22]. Our study found that the 
homocysteine concentrations of patients during 
their acute phases were low, attributed to the 
increase in its excretion through urine. 
Consequently, this suggested that 
homocysteine alteration occurred in patients as 
a result of NS and was not responsible for the 
pathogenesis of the disease.  
In the literature, homocysteine concentrations 
during the proteinuria phase were found to be 
high compared to the concentrations in healthy 
children; however, the reason for this could not 
be clarified [23,24]. In other most studies, 
though, it has been reported that serum 
homocysteine concentrations decreased 
depending on urinary excretion during the 
proteinuria phase and returned to normal during 
remission [25]. Homocysteine levels predicted 
damage accrual independently and is 
considered as proinflammatory marker in SLE 
patients [26,27].  In our patients, the decreased 
serum homocysteine concentrations during the 
proteinuria phase were higher than the values of 
those in the control group. Our findings were 
compatible with the recent study conducted by 
Tkaczyk et al. [28]. Their study further revealed 
that while the serum homocysteine 
concentrations were low during the proteinuria 
phase, they began to increase two weeks later 
and were considerably higher than those of the 
control group after eight weeks. Tkaczyk et al. 
[29] also found that the administration of 
cyclosporine A caused a significant increase in 
homocysteine and cysteine concentrations. 
However, we can infer that this abnormal 
increase may have been a reactional increase 
related to steroid use to treat NS, similar to the 
treatment of polymyalgia rheumatica [30].  
After the use of vitamin B6, B12 and folic acid 
in the same patient group, the homocysteine 
concentrations decreased again [30,31]. 
Although another study showed that 
homocysteine concentrations were low during 
the proteinuria phase, they normalized during 
remission at 12 weeks and 1 year. [32]. 
Therefore, when patients went into remission, 
these vitamin concentrations could be seen to 
decline and the homocysteine concentrations to 
increase. Elevated homocysteine 
concentrations during steroid treatment were 
associated with endothelium dysfunction and 
atherosclerosis; although vitamin 
concentrations were not measured in our study, 
vitamin supplementation is suggested based on 
estimation of low vitamin concentrations. 
Modulation of endothelial dysfunction in 
children with NS may be considered a 
therapeutic strategy to decrease the risk of 
future adverse cardiovascular events [33].  
Indeed, if serial homocysteine concentrations 
had been determined at certain intervals after 
steroid treatment was ceased, this hypothesis 
would have been supported.  
A positive relationship was determined 
between the homocysteine concentrations, the 
body mass index (BMI) and the serum total IgG 
concentrations alongside an established 
negative relationship between the erythrocyte 
sedimentation rates (ESR) and the total 
cholesterol and LDL-cholesterol 
concentrations. As BMI can be deceptive owing 
to the edematous period in NS, the relationship 
between the homocysteine concentrations and 
BMI was ignored. Nevertheless, when other 
data was analyzed carefully, they were all 
observed to be associated with the activity of 
the disease. In order to determine the most 
important independent predictor that could lead 
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to low concentrations of homocysteine, 
multiple logistic regression was applied. In our 
study, elevated ESR was observed as single 
independent predictor when stepwise linear 
logistic regression was applied to factors that 
causes low homocysteine concentration.  ESR 
is the index of inflammatory activity and gives 
an indication regarding the progress of the 
disease and response to treatment. Therefore, 
this finding states that low homocysteine 
concentration could be another parameter in 
addition to ESR which indicates severity and 
response to treatment as a surrogate marker. 
The long-term effects of alterations on the 
homocysteine concentrations in patients will be 
possible only through randomized prospective 
studies. The long-term effects of homocysteine 
in NS are unexplored issues for future studies.  
Another important finding of our study was 
being significant difference between serum 
insulin concentrations of patients and 
homeostasis model assessment of insulin 
resistance (HOMA-IR) values during the active 
and remission phases. Although only two 
patients (5%) had a high HOMA-IR value 
(≥2.5) during the active phase, HOMA-IR 
values were found as ≥2.5 in sixteen out of forty 
patients (40%) after steroid treatment in 
remission phase. Furthermore, the serum 
fasting insulin concentrations of remission 
phase were significantly higher than those of 
active phase. Thus, discovering both insulin 
concentrations and HOMA-IR values at high 
concentrations in patients receiving steroid 
treatment indicated the development of insulin 
resistance. As the therapeutic benefits of 
glucocorticoids continue to expand across 
medical specialties, the incidence of steroid-
induced insulin resistance will continue to rise 
[34].  If these patients do not have to use 
steroids again, over time these values will partly 
or totally return to normal.  
The major limitation of this study was the lack 
of urinary analyses. Unfortunately, we did not 
study the urinary homocysteine and leptin 
concentrations of the patients. Another 
important limitation was the lack of frequent 
measurement of the serum homocysteine, leptin 
concentrations and vitamin levels during the 
steroid treatment. Last limitation of the study 
was difference of BMI between the study and 
the control group, which was adjusted by 
considering as a confounder. 
 
Conclusion 
In this study, we demonstrated that serum leptin 
and homocysteine concentrations decreased in 
active phase and increased in remission phase 
in children with NS. This decrease was likely 
caused by excretion via urine and is an 
important parameter revealing the activity of 
the illness. In addition, temporary or permanent 
insulin resistance could develop as a result of 
steroid use in a short period of time for this 
patient group. These and future studies will be 
crucial for understanding the pathogenesis of 
NS and determining treatment approaches. 
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